Informa
TIDES USA: Oligonucleotide & Peptide Therapeutics
2025³â 5¿ù 19-22ÀÏ
Manchester Grand Hyatt San Diego, CA, USA
TIDES USA: Oligonucleotide & Peptide Therapeutics 2025
ÀÏÁ¤ : 2025³â 5¿ù 19-22ÀÏ
°³ÃÖ: Manchester Grand Hyatt San Diego, CA, USA

TIDES USA : ¿¬±¸¿Í Çö½ÇÀÇ °¡±³

ÆÄÀÌ¿À´Ï¾î°¡ ¾ÆÀ̵ð¾î¸¦ °øÀ¯Çϰí, ÀǾàÀÇ ½ÃÀå ÅõÀÔÀ» °¡¼Ó½ÃŰ´Â Àå¼Ò

ºÏ¹ÌÀÇ ÇÁ¸®¹Ì¾î Æ÷·³ TIDES USA¿¡¼­´Â °øµ¿ ¹ß°ß¡¤°³¹ß¡¤»ó¾÷È­¿¡ ÀÇÇØ ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå¿Í ÆéƼµå Çõ½ÅÀ» °¡¼Ó½Ãŵ´Ï´Ù. ¾÷°è ÆÄÀÌ¿À´Ï¾î°¡ ÀǾàÀ» ¹ß°ßÀ¸·ÎºÎÅÍ Çö½Ç ½ÃÀåÀ¸·Î º¯Çõ½Ã۱â À§ÇØ ¿Ã¸®°í¡¤ÆéƼµå¡¤mRNA¡¤À¯ÀüÀÚ ÆíÁý¿¡¼­ ÃÖ÷´Ü Àü·«À» ¸ð»öÇÕ´Ï´Ù.

¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå¡¤ÆéƼµå¡¤mRNA¡¤À¯ÀüÀÚ ÆíÁý¡¤Àü´Þ

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

¼öÄ¡·Î º¸´Â TIDES USA

1900+

Attendees

150+

Industry Speakers

170+

Sponsors

8

Workshops

5

Tracks

TIDES USA 2025¿¡ Âü°¡ÇÏ´Â ÀÌÀ¯ : °úÇÐ Çõ½Å°ú Çù¾÷À¸·ÎÀÇ ÀÔ±¸

¾÷°è Ⱦ´ÜÀû Çõ½Å ±³·ù

º¹¼öÀÇ ºÐ¾ßÀÇ ¾÷°è Àü¹®°¡¿Í ±³·ùÇϰí, ÀλçÀÌÆ®¸¦ °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀ» Ã˹ßÇÏ°í ±âÁ¸ »ç°í¿¡ µµÀüÇϸç Ä¡·áÁ¦ °³¹ßÀÇ È¹±âÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î À̾îÁö´Â dzºÎÇÑ µð½ºÄ¿¼Ç¿¡ Âü°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü¹®ÀûÀÎ °úÇÐ ÄÁÅÙÃ÷

ƯÁ¤ ¹®Á¦¿¡ ´ëÇØ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â Àú¸íÇÑ °úÇÐÀÚ¿¡°Ô Á÷Á¢ ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÁýÁßÀûÀÎ ±³·ù¿¡ ÀÇÇØ ¿¬±¸ ¾îÇÁ·ÎÄ¡¸¦ °³¼±Çϰí, ±â¼úÀû Àå¾Ö¹°À» ±Øº¹Çϱâ À§ÇÑ Æ¯º°ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

¿¬±¸ ¹ßÇ¥ ±âȸ

Æ÷½ºÅÍ ¹ßÇ¥ ÇÁ·Î±×·¥¿¡ ÀÇÇØ ÃֽаúÇÐÀû ºê·¹ÀÌÅ©½º·ç¸¦ ¹ßÇ¥ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÚ½ÅÀÇ ¿¬±¸ ¼º°ú°¡ ½ÇÁ¦ Àü½ÃȦ°ú µðÁöÅÐ Ç÷§Æû(ConnectMe) ¾çÃø¿¡ Àü½ÃµÇ¸ç, ÀáÀçÀûÀÎ Çù·ÂÀÚ¿¡°Ô ÀÎÁöµµ¸¦ ÃÖ´ëÇÑ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

÷´Ü ±â¼ú ¼îÄÉÀ̽º

Á¾ÇÕ Àü½ÃȦ¿¡¼­ Ãֽбâ¼ú Çõ½ÅÀ» Á÷Á¢ üÇèÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß ÇÁ·Î¼¼½º¿¡ Çõ¸íÀ» °¡Á®¿À´Â ÃÖ÷´Ü Åø°ú ¼Ö·ç¼ÇÀ» ¼Ò°³ÇÕ´Ï´Ù.

»ý¸í°úÇÐÀÇ Ãµ±¹ : »÷µð¿¡°í

1,200»ç ÀÌ»óÀÇ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÌ ÀÖ°í ¿¬Áß ³»³» ¿Ïº®ÇÑ ³¯¾¾¸¦ ÀÚ¶ûÇÏ´Â »÷µð¿¡À̰íÀÇ ¹ø¼ºÇÏ´Â »ý¸í°úÇÐ Çãºê´Â °úÇÐÀû Çù¾÷°ú ³×Æ®¿öÅ·À» À§ÇÑ È°±âÂù ȯ°æÀ» Á¦°øÇÕ´Ï´Ù.

µðÁöÅÐ ÄÁÆÛ·±½ºÀÇ °­È­

¾ÆÁ¨´Ù, Âü°¡ÀÚ ¸®½ºÆ®, ¸ÅÄ¡¸ÞÀÌÅ· ±â´É, ½É¸®½º ½ºÄÉÁÙ ÅøÀ» °®Ãá ConnectMe ¾ÛÀÇ È°¿ëÀ¸·Î ÄÁÆÛ·±½º °æÇèÀ» ÃÖ´ëÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¾÷µ¥ÀÌÆ®¿¡ ÀÇÇØ ÅëÇÕ µðÁöÅÐ Ç÷§Æû °æÀ¯·Î ³×Æ®¿öÅ· ±âȸ¸¦ È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

TIDES¿¡¼­´Â ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå¡¤ÆéƼµå¡¤mRNA¡¤À¯ÀüÀÚ ÆíÁý¡¤¾à¹°Àü´ÞÀÇ Àü¹®¼ºÀ» °øÀ¯

TIDES USA¿¡¼­´Â ³ª¸¸ÀÇ ¸ÂÃãÇü ¾ÆÁ¨´Ù¸¦ ÀÛ¼ºÇÏ´Â °ÍÀ¸·Î °íÀ¯ÀÇ Ä¿½ºÅ͸¶ÀÌÁî ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. 6°³ÀÇ µ¿½Ã °³ÃÖ Æ®·¢¿¡¼­ 200°³ ÀÌ»óÀÇ ÇÁ·¹Á¨Å×ÀÌ¼Ç Áß ¼±ÅÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå CMC(È­ÇС¤Á¦Á¶¡¤Ç°Áú°ü¸®)

• ÃÖÀûÈ­µÈ CMC Àü·«À¸·Î °³¹ßÀÇ °¡¼Ó

• Â÷¼¼´ë ºÐ¼® ¹æ¹ý°ú QCÀÇ ½Àµæ

• ½ÃÀå¿¡ ´ëÇÑ ±ÔÁ¦ °æ·ÎÀÇ ÇÕ¸®È­

• ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¦Á¶ÀÇ È®´ë

¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå ¹ß°ß¡¤ÀüÀÓ»ó¡¤ÀÓ»ó

• ȹ±âÀûÀÎ ¾à¹° À¯»ç Ư¼ºÀÇ ¼³°è

• Èĺ¸ ¹°ÁúÀÇ ½Å¼ÓÇÑ ¼±Á¤

• ÀÓ»ó½ÃÇè ¼³°èÀÇ ÃÖÀûÈ­

• ¾÷°è ¸®´õ¿¡ ´ëÇÑ º¥Ä¡¸¶Å©

ÆéƼµå CMC(È­ÇС¤Á¦Á¶¡¤Ç°Áú°ü¸®)

• ¼ö·®°ú ÇÁ·Î¼¼½º È¿À²ÀÇ ÃÖ´ëÈ­

• º¹ÀâÇÑ ±ÔÁ¦ ¿ä°ÇÀÇ ´ëÀÀ

• ÃÖ÷´Ü QC ±â¼úÀÇ ½ÇÀå

• ½Å±Ô ºÐÀÚÀÇ ¹®Á¦ ¼÷Áö

ÆéƼµå ¹ß°ß¡¤ÀüÀÓ»ó¡¤ÀÓ»ó

• ¿ì¼öÇÑ ÆéƼµå ¼³°è °øÇÐ

• Àü´Þ ½Ã½ºÅÛÀÇ Çõ½Å

• ¹ß°ß ÆÄÀÌÇÁ¶óÀÎÀÇ °¡¼Ó

• ÀÓ»ó ¼º°ø »ç·Ê·ÎºÎÅÍ ÇнÀ

mRNA ÀǾà/¹é½Å¡¤À¯ÀüÀÚ ÆíÁý

• mRNA ¼³°è ºê·¹ÀÌÅ©½º·çÀÇ ÆÄÀÌ¿À´Ï¾î

• ÷´Ü Àü´Þ ±â¼úÀÇ ½Àµæ

• À¯ÀüÀÚ ÆíÁý ±â´ÉÀÇ º¯Çõ

• Á¦Á¶ÀÇ È®´ë¿¡ ¼º°ø

¾à¹°Àü´Þ Çõ½Å

• Ç¥Àû Àü´Þ ¼Ö·ç¼Ç ÇØ¹æ

• °æ±¸ ÆéƼµå Àü´Þ ÆÄÀÌ¿À´Ï¾î

• µð¹ÙÀ̽º ±â¹Ý Àü·«ÀÇ Çõ½Å

• °íºÐÀÚ Àü´ÞÀÇ ÃÖÀûÈ­

ÃÖ°íÀÇ ÀáÀç °í°´°ú ¾Ç¼ö!

½ºÆù¼­¡¤Àü½Ã¡¤±¤°í ±âȸ¿¡ ´ëÇØ¼­´Â (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀ¸·Î ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù.

Mike Pennington, Ph.D.

Chief Scientific Officer

AmbioPharm, Inc.

With the current situation facing the world with the Covid-19 pandemic, we fully support the digital format that is being offered for the TIDES meeting(s). The digital format will still allow AmbioPharm to reach out to our existing as well as new potential clients. This is the right decision for all of us.

Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.

Bruce Morimoto, Ph.D.

Vice President, Drug Development-Operations

Alkahest, USA

TIDES USA has been my go-to meeting to learn about the latest trends and scientific developments in the peptide and oligonucleotide field. The global pandemic has challenged us to find alternative venues to obtain the critical content necessary for us to continue to push the boundaries of innovation. TIDES provides this platform by integrating research and discovery with development and manufacturing. The digital meeting format will surely provide the high-quality content I have come to expect from the TIDES conference series.

Mike Pennington, Ph.D.

Chief Scientific Officer

AmbioPharm, Inc.

With the current situation facing the world with the Covid-19 pandemic, we fully support the digital format that is being offered for the TIDES meeting(s). The digital format will still allow AmbioPharm to reach out to our existing as well as new potential clients. This is the right decision for all of us.

Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.

Bruce Morimoto, Ph.D.

Vice President, Drug Development-Operations

Alkahest, USA

TIDES USA has been my go-to meeting to learn about the latest trends and scientific developments in the peptide and oligonucleotide field. The global pandemic has challenged us to find alternative venues to obtain the critical content necessary for us to continue to push the boundaries of innovation. TIDES provides this platform by integrating research and discovery with development and manufacturing. The digital meeting format will surely provide the high-quality content I have come to expect from the TIDES conference series.

Mike Pennington, Ph.D.

Chief Scientific Officer

AmbioPharm, Inc.

With the current situation facing the world with the Covid-19 pandemic, we fully support the digital format that is being offered for the TIDES meeting(s). The digital format will still allow AmbioPharm to reach out to our existing as well as new potential clients. This is the right decision for all of us.